English

엔지켐생명과학

DART

Filing (반기보고서 (2026.06)) · filed 2026-08-14

Annual consolidated revenue for 2025: about KRW 67.75B, using the latest reported figures. The previous period, 2024, was about KRW 77.38B.

Inspect reported changes Compare with another company Historical disclosures Segments

Watchlist

Latest quarter

Revenue

23.5 billion KRW

2026-06-30 · KRW

Exact inputs and evidence

Revenue: 23543043251 KRW Source

Operating margin

-17.28%

2026-06-30 · %

Exact inputs and evidence

Operating Income: -4068322968 KRW Source
Revenue: 23543043251 KRW Source

Operating cash flow

-6.78 billion KRW

2026-06-30 · KRW

Exact inputs and evidence

Operating Cash Flow: -9573389784 KRW Source
Operating Cash Flow: -2788419391 KRW Source

Cash and cash equivalents: 24.9 billion KRW 2026-06-30 Source
Exact value

24922783673 KRW
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

69 billion KRW

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 16470733029 KRW · 2025-07-01 – 2025-09-30 Source
Revenue: 67750824736 KRW · 2025-01-01 – 2025-12-31 Source
Revenue: 53654651815 KRW · 2025-01-01 – 2025-09-30 Source
Revenue: 14892258100 KRW · 2026-01-01 – 2026-03-31 Source
Revenue: 23543043251 KRW · 2026-04-01 – 2026-06-30 Source

Net income

-18 billion KRW

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -3306289548 KRW · 2025-07-01 – 2025-09-30 Source
Net income: -18131506687 KRW · 2025-01-01 – 2025-12-31 Source
Net income: -8230568802 KRW · 2025-01-01 – 2025-09-30 Source
Net income: -1855494655 KRW · 2026-01-01 – 2026-03-31 Source
Net income: -2933936483 KRW · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-19.2 billion KRW

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -2482473032 KRW · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -1378925120 KRW · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -11012139984 KRW · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -2482473032 KRW · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -2788419391 KRW · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -9573389784 KRW · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -2788419391 KRW · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-14.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2025-12-31
Operating income: 9 of 11 periods available· newest 2025-12-31
Net income: 9 of 11 periods available· newest 2025-12-31
Operating cash flow: 9 of 11 periods available· newest 2025-12-31
capital expenditure: No compatible figures in this window
Total assets: 9 of 11 periods available· newest 2025-12-31
Total liabilities: 9 of 11 periods available· newest 2025-12-31
Current assets: 9 of 11 periods available· newest 2025-12-31
Current liabilities: 9 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-12.4%

Prior period

KRW 77.38 billion

2024-01-01 – 2024-12-31
Current period

KRW 67.75 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

67750824736 − 77377688864 = -9626864128 KRW

77377688864 KRW · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
67750824736 KRW · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · 엔지켐생명과학 · 2025-12-31 엔지켐생명과학 (dart:00606886) Year-over-year change in Revenue: -9626864128 KRW Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/dart/00606886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 67750824736 KRW (2025-01-01 to 2025-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#249867 Filing: 20260324000019 Input fundies:Revenue: 77377688864 KRW (2024-01-01 to 2024-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#177498 Filing: 20260324000019
The citation records this snapshot. The page link may show a newer release later.
Net income
+KRW 3.98 billion

Prior period

−KRW 22.11 billion

2024-01-01 – 2024-12-31
Current period

−KRW 18.13 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

-18131506687 − -22106613850 = 3975107163 KRW

-22106613850 KRW · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-18131506687 KRW · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · 엔지켐생명과학 · 2025-12-31 엔지켐생명과학 (dart:00606886) Year-over-year change in Net income: 3975107163 KRW Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/dart/00606886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -18131506687 KRW (2025-01-01 to 2025-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#247479 Filing: 20260324000019 Input fundies:NetIncome: -22106613850 KRW (2024-01-01 to 2024-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#179377 Filing: 20260324000019
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−KRW 10.44 billion

Prior period

−KRW 573.93 million

2024-01-01 – 2024-12-31
Current period

−KRW 11.01 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

-11012139984 − -573927332 = -10438212652 KRW

-573927332 KRW · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-11012139984 KRW · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · 엔지켐생명과학 · 2025-12-31 엔지켐생명과학 (dart:00606886) Year-over-year change in Operating cash flow: -10438212652 KRW Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: Consolidated View: https://fundies.io/companies/dart/00606886?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -11012139984 KRW (2025-01-01 to 2025-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#380257 Filing: 20260324000019 Input fundies:OperatingCashFlow: -573927332 KRW (2024-01-01 to 2024-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#314200 Filing: 20260324000019
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue KRW 67.75 billion 100% of revenue
Operating costs Derived KRW 82.09 billion 121% of revenue
Operating income −KRW 14.34 billion −21% of revenue
Tax, interest and other Derived KRW 3.79 billion 5.6% of revenue
Net income −KRW 18.13 billion −27% of revenue

Cash

Operating cash flow −KRW 11.01 billion −16% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 121% of revenue.
2018 Operating loss: operating costs were 146% of revenue.
2019 Operating loss: operating costs were 152% of revenue.
2020 Operating loss: operating costs were 174% of revenue.
2021 Operating loss: operating costs were 190% of revenue.
2022 Operating loss: operating costs were 155% of revenue.
2023 Operating loss: operating costs were 119% of revenue.
2024 Operating loss: operating costs were 117% of revenue.
2025 Operating loss: operating costs were 121% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	26133210513	31513640316 Derived	-5380429803	285997800 Derived	-5666427603	Unavailable	Source 2017-01-01 – 2017-12-31: 26133210513 KRW Inspect Revenue Open source 2017-01-01 – 2017-12-31: -5380429803 KRW Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -5666427603 KRW Inspect Net Income Open source 2017-01-01 – 2017-12-31: -5206533268 KRW Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	31034039114	45363255235 Derived	-14329216121	91014781 Derived	-14420230902	Unavailable	Source 2018-01-01 – 2018-12-31: 31034039114 KRW Inspect Revenue Open source 2018-01-01 – 2018-12-31: -14329216121 KRW Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -14420230902 KRW Inspect Net Income Open source 2018-01-01 – 2018-12-31: -13524531987 KRW Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	31468723444	47870904201 Derived	-16402180757	476895783 Derived	-16879076540	Unavailable	Source 2019-01-01 – 2019-12-31: 31468723444 KRW Inspect Revenue Open source 2019-01-01 – 2019-12-31: -16402180757 KRW Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -16879076540 KRW Inspect Net Income Open source 2019-01-01 – 2019-12-31: -15095427506 KRW Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	25818432585	44925875549 Derived	-19107442964	-1600514967 Derived	-17506927997	Unavailable	Source 2020-01-01 – 2020-12-31: 25818432585 KRW Inspect Revenue Open source 2020-01-01 – 2020-12-31: -19107442964 KRW Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -17506927997 KRW Inspect Net Income Open source 2020-01-01 – 2020-12-31: -14020851848 KRW Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	22975498508	43729014824 Derived	-20753516316	7111316526 Derived	-27864832842	Unavailable	Source 2021-01-01 – 2021-12-31: 22975498508 KRW Inspect Revenue Open source 2021-01-01 – 2021-12-31: -20753516316 KRW Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -27864832842 KRW Inspect Net Income Open source 2021-01-01 – 2021-12-31: -18588946246 KRW Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	26637631236	41299409018 Derived	-14661777782	10431331928 Derived	-25093109710	Unavailable	Source 2022-01-01 – 2022-12-31: 26637631236 KRW Inspect Revenue Open source 2022-01-01 – 2022-12-31: -14661777782 KRW Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -25093109710 KRW Inspect Net Income Open source 2022-01-01 – 2022-12-31: -14319893548 KRW Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	76038893905	90395038600 Derived	-14356144695	-5029733181 Derived	-9326411514	Unavailable	Source 2023-01-01 – 2023-12-31: 76038893905 KRW Inspect Revenue Open source 2023-01-01 – 2023-12-31: -14356144695 KRW Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -9326411514 KRW Inspect Net Income Open source 2023-01-01 – 2023-12-31: -10257939603 KRW Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	77377688864	90571658630 Derived	-13193969766	8912644084 Derived	-22106613850	Unavailable	Source 2024-01-01 – 2024-12-31: 77377688864 KRW Inspect Revenue Open source 2024-01-01 – 2024-12-31: -13193969766 KRW Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -22106613850 KRW Inspect Net Income Open source 2024-01-01 – 2024-12-31: -573927332 KRW Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	67750824736	82087538890 Derived	-14336714154	3794792533 Derived	-18131506687	Unavailable	Source 2025-01-01 – 2025-12-31: 67750824736 KRW Inspect Revenue Open source 2025-01-01 – 2025-12-31: -14336714154 KRW Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -18131506687 KRW Inspect Net Income Open source 2025-01-01 – 2025-12-31: -11012139984 KRW Inspect Operating Cash Flow Open source

Amounts are exact, in KRW.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

KRW 67.8B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(KRW)	Source evidence
20172017-12-31	Revenue	26133210513	Revenue: 26133210513 Open source
20182018-12-31	Revenue	31034039114	Revenue: 31034039114 Open source
20192019-12-31	Revenue	31468723444	Revenue: 31468723444 Open source
20202020-12-31	Revenue	25818432585	Revenue: 25818432585 Open source
20212021-12-31	Revenue	22975498508	Revenue: 22975498508 Open source
20222022-12-31	Revenue	26637631236	Revenue: 26637631236 Open source
20232023-12-31	Revenue	76038893905	Revenue: 76038893905 Open source
20242024-12-31	Revenue	77377688864	Revenue: 77377688864 Open source
20252025-12-31	Revenue	67750824736	Revenue: 67750824736 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-12.4% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 26133210513 Open source
20182018-12-31	Year over year	18.8%	Revenue: 31034039114 Open source Revenue: 26133210513 Open source
20192019-12-31	Year over year	1.4%	Revenue: 31468723444 Open source Revenue: 31034039114 Open source
20202020-12-31	Year over year	-18%	Revenue: 25818432585 Open source Revenue: 31468723444 Open source
20212021-12-31	Year over year	-11%	Revenue: 22975498508 Open source Revenue: 25818432585 Open source
20222022-12-31	Year over year	15.9%	Revenue: 26637631236 Open source Revenue: 22975498508 Open source
20232023-12-31	Year over year	185.5%	Revenue: 76038893905 Open source Revenue: 26637631236 Open source
20242024-12-31	Year over year	1.8%	Revenue: 77377688864 Open source Revenue: 76038893905 Open source
20252025-12-31	Year over year	-12.4%	Revenue: 67750824736 Open source Revenue: 77377688864 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -21.2% 2025

Net margin -26.8% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-20.6%	Operating Income: -5380429803 Open source Revenue: 26133210513 Open source
20182018-12-31	Operating margin	-46.2%	Operating Income: -14329216121 Open source Revenue: 31034039114 Open source
20192019-12-31	Operating margin	-52.1%	Operating Income: -16402180757 Open source Revenue: 31468723444 Open source
20202020-12-31	Operating margin	-74%	Operating Income: -19107442964 Open source Revenue: 25818432585 Open source
20212021-12-31	Operating margin	-90.3%	Operating Income: -20753516316 Open source Revenue: 22975498508 Open source
20222022-12-31	Operating margin	-55%	Operating Income: -14661777782 Open source Revenue: 26637631236 Open source
20232023-12-31	Operating margin	-18.9%	Operating Income: -14356144695 Open source Revenue: 76038893905 Open source
20242024-12-31	Operating margin	-17.1%	Operating Income: -13193969766 Open source Revenue: 77377688864 Open source
20252025-12-31	Operating margin	-21.2%	Operating Income: -14336714154 Open source Revenue: 67750824736 Open source
20172017-12-31	Net margin	-21.7%	Net Income: -5666427603 Open source Revenue: 26133210513 Open source
20182018-12-31	Net margin	-46.5%	Net Income: -14420230902 Open source Revenue: 31034039114 Open source
20192019-12-31	Net margin	-53.6%	Net Income: -16879076540 Open source Revenue: 31468723444 Open source
20202020-12-31	Net margin	-67.8%	Net Income: -17506927997 Open source Revenue: 25818432585 Open source
20212021-12-31	Net margin	-121.3%	Net Income: -27864832842 Open source Revenue: 22975498508 Open source
20222022-12-31	Net margin	-94.2%	Net Income: -25093109710 Open source Revenue: 26637631236 Open source
20232023-12-31	Net margin	-12.3%	Net Income: -9326411514 Open source Revenue: 76038893905 Open source
20242024-12-31	Net margin	-28.6%	Net Income: -22106613850 Open source Revenue: 77377688864 Open source
20252025-12-31	Net margin	-26.8%	Net Income: -18131506687 Open source Revenue: 67750824736 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 26133210513 Open source Operating Cash Flow: -5206533268 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 31034039114 Open source Operating Cash Flow: -13524531987 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 31468723444 Open source Operating Cash Flow: -15095427506 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 25818432585 Open source Operating Cash Flow: -14020851848 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 22975498508 Open source Operating Cash Flow: -18588946246 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 26637631236 Open source Operating Cash Flow: -14319893548 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 76038893905 Open source Operating Cash Flow: -10257939603 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 77377688864 Open source Operating Cash Flow: -573927332 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 67750824736 Open source Operating Cash Flow: -11012139984 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

KRW -11B 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(KRW)	Source evidence
20172017-12-31	Operating cash flow	-5206533268	Operating Cash Flow: -5206533268 Open source
20182018-12-31	Operating cash flow	-13524531987	Operating Cash Flow: -13524531987 Open source
20192019-12-31	Operating cash flow	-15095427506	Operating Cash Flow: -15095427506 Open source
20202020-12-31	Operating cash flow	-14020851848	Operating Cash Flow: -14020851848 Open source
20212021-12-31	Operating cash flow	-18588946246	Operating Cash Flow: -18588946246 Open source
20222022-12-31	Operating cash flow	-14319893548	Operating Cash Flow: -14319893548 Open source
20232023-12-31	Operating cash flow	-10257939603	Operating Cash Flow: -10257939603 Open source
20242024-12-31	Operating cash flow	-573927332	Operating Cash Flow: -573927332 Open source
20252025-12-31	Operating cash flow	-11012139984	Operating Cash Flow: -11012139984 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(KRW)	Source evidence
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5206533268 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -13524531987 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -15095427506 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -14020851848 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: -18588946246 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -14319893548 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -10257939603 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -573927332 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -11012139984 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

6.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Liabilities / assets	33.3%	Total Liabilities: 12242076264 Open source Total Assets: 36804545500 Open source
20182018-12-31	Liabilities / assets	12.3%	Total Liabilities: 8228884533 Open source Total Assets: 67045474396 Open source
20192019-12-31	Liabilities / assets	12.9%	Total Liabilities: 10950625229 Open source Total Assets: 84991166472 Open source
20202020-12-31	Liabilities / assets	41.5%	Total Liabilities: 51319665897 Open source Total Assets: 123802205798 Open source
20212021-12-31	Liabilities / assets	43.9%	Total Liabilities: 58422235975 Open source Total Assets: 133084134205 Open source
20222022-12-31	Liabilities / assets	18.5%	Total Liabilities: 45810906530 Open source Total Assets: 247554986724 Open source
20232023-12-31	Liabilities / assets	8%	Total Liabilities: 16918865199 Open source Total Assets: 211545507317 Open source
20242024-12-31	Liabilities / assets	11.1%	Total Liabilities: 20261120319 Open source Total Assets: 181743940859 Open source
20252025-12-31	Liabilities / assets	6.6%	Total Liabilities: 9825288149 Open source Total Assets: 148592462348 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

14.06× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	2.48×	Current Assets: 24527647717 Open source Current Liabilities: 9874467288 Open source
20182018-12-31	Current assets / current liabilities	7.8×	Current Assets: 50223760284 Open source Current Liabilities: 6440894033 Open source
20192019-12-31	Current assets / current liabilities	8.43×	Current Assets: 63236294574 Open source Current Liabilities: 7498916998 Open source
20202020-12-31	Current assets / current liabilities	10.73×	Current Assets: 104998820775 Open source Current Liabilities: 9783831404 Open source
20212021-12-31	Current assets / current liabilities	2.05×	Current Assets: 109783111978 Open source Current Liabilities: 53620511593 Open source
20222022-12-31	Current assets / current liabilities	5.21×	Current Assets: 220312757517 Open source Current Liabilities: 42284411133 Open source
20232023-12-31	Current assets / current liabilities	12.33×	Current Assets: 174475031331 Open source Current Liabilities: 14154097238 Open source
20242024-12-31	Current assets / current liabilities	13.03×	Current Assets: 148230247322 Open source Current Liabilities: 11374846566 Open source
20252025-12-31	Current assets / current liabilities	14.06×	Current Assets: 115773795160 Open source Current Liabilities: 8232198108 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2017 2017-01-01 – 2017-12-31	−KRW 5.67 billion Exact value Exact value: -5666427603 KRW 2017-01-01 – 2017-12-31: -5666427603 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2017-12-31 엔지켐생명과학 (dart:00606886) Net Income: -5666427603 KRW Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -5666427603 KRW (2017-01-01 to 2017-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20200330003010&reprt_code=11011#384755 Filing: 20200330003010 The citation records this snapshot. The page link may show a newer release later.	−KRW 5.21 billion Exact value Exact value: -5206533268 KRW 2017-01-01 – 2017-12-31: -5206533268 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2017-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -5206533268 KRW Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -5206533268 KRW (2017-01-01 to 2017-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20200330003010&reprt_code=11011#295918 Filing: 20200330003010 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−KRW 14.42 billion Exact value Exact value: -14420230902 KRW 2018-01-01 – 2018-12-31: -14420230902 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2018-12-31 엔지켐생명과학 (dart:00606886) Net Income: -14420230902 KRW Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -14420230902 KRW (2018-01-01 to 2018-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20210323000637&reprt_code=11011#426762 Filing: 20210323000637 The citation records this snapshot. The page link may show a newer release later.	−KRW 13.52 billion Exact value Exact value: -13524531987 KRW 2018-01-01 – 2018-12-31: -13524531987 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2018-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -13524531987 KRW Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -13524531987 KRW (2018-01-01 to 2018-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20210323000637&reprt_code=11011#333921 Filing: 20210323000637 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−KRW 16.88 billion Exact value Exact value: -16879076540 KRW 2019-01-01 – 2019-12-31: -16879076540 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2019-12-31 엔지켐생명과학 (dart:00606886) Net Income: -16879076540 KRW Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -16879076540 KRW (2019-01-01 to 2019-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20220802000113&reprt_code=11011#441663 Filing: 20220802000113 The citation records this snapshot. The page link may show a newer release later.	−KRW 15.1 billion Exact value Exact value: -15095427506 KRW 2019-01-01 – 2019-12-31: -15095427506 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2019-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -15095427506 KRW Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -15095427506 KRW (2019-01-01 to 2019-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20220802000113&reprt_code=11011#345433 Filing: 20220802000113 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−KRW 17.51 billion Exact value Exact value: -17506927997 KRW 2020-01-01 – 2020-12-31: -17506927997 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2020-12-31 엔지켐생명과학 (dart:00606886) Net Income: -17506927997 KRW Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -17506927997 KRW (2020-01-01 to 2020-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20230321000772&reprt_code=11011#446232 Filing: 20230321000772 The citation records this snapshot. The page link may show a newer release later.	−KRW 14.02 billion Exact value Exact value: -14020851848 KRW 2020-01-01 – 2020-12-31: -14020851848 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2020-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -14020851848 KRW Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -14020851848 KRW (2020-01-01 to 2020-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20230321000772&reprt_code=11011#344138 Filing: 20230321000772 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−KRW 27.86 billion Exact value Exact value: -27864832842 KRW 2021-01-01 – 2021-12-31: -27864832842 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2021-12-31 엔지켐생명과학 (dart:00606886) Net Income: -27864832842 KRW Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -27864832842 KRW (2021-01-01 to 2021-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20240320000827&reprt_code=11011#288040 Filing: 20240320000827 The citation records this snapshot. The page link may show a newer release later.	−KRW 18.59 billion Exact value Exact value: -18588946246 KRW 2021-01-01 – 2021-12-31: -18588946246 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2021-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -18588946246 KRW Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -18588946246 KRW (2021-01-01 to 2021-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20240320000827&reprt_code=11011#281077 Filing: 20240320000827 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−KRW 25.09 billion Exact value Exact value: -25093109710 KRW 2022-01-01 – 2022-12-31: -25093109710 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2022-12-31 엔지켐생명과학 (dart:00606886) Net Income: -25093109710 KRW Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -25093109710 KRW (2022-01-01 to 2022-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20250318000840&reprt_code=11011#99656 Filing: 20250318000840 The citation records this snapshot. The page link may show a newer release later.	−KRW 14.32 billion Exact value Exact value: -14319893548 KRW 2022-01-01 – 2022-12-31: -14319893548 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2022-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -14319893548 KRW Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -14319893548 KRW (2022-01-01 to 2022-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20250318000840&reprt_code=11011#229435 Filing: 20250318000840 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−KRW 9.33 billion Exact value Exact value: -9326411514 KRW 2023-01-01 – 2023-12-31: -9326411514 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2023-12-31 엔지켐생명과학 (dart:00606886) Net Income: -9326411514 KRW Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -9326411514 KRW (2023-01-01 to 2023-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#150648 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	−KRW 10.26 billion Exact value Exact value: -10257939603 KRW 2023-01-01 – 2023-12-31: -10257939603 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2023-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -10257939603 KRW Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -10257939603 KRW (2023-01-01 to 2023-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#313945 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−KRW 22.11 billion Exact value Exact value: -22106613850 KRW 2024-01-01 – 2024-12-31: -22106613850 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2024-12-31 엔지켐생명과학 (dart:00606886) Net Income: -22106613850 KRW Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -22106613850 KRW (2024-01-01 to 2024-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#179377 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	−KRW 573.93 million Exact value Exact value: -573927332 KRW 2024-01-01 – 2024-12-31: -573927332 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2024-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -573927332 KRW Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -573927332 KRW (2024-01-01 to 2024-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#314200 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−KRW 18.13 billion Exact value Exact value: -18131506687 KRW 2025-01-01 – 2025-12-31: -18131506687 KRW Inspect Net Income Open source Share or cite Citation for Net Income · 엔지켐생명과학 · 2025-12-31 엔지켐생명과학 (dart:00606886) Net Income: -18131506687 KRW Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:NetIncome: -18131506687 KRW (2025-01-01 to 2025-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#247479 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	−KRW 11.01 billion Exact value Exact value: -11012139984 KRW 2025-01-01 – 2025-12-31: -11012139984 KRW Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · 엔지켐생명과학 · 2025-12-31 엔지켐생명과학 (dart:00606886) Operating Cash Flow: -11012139984 KRW Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-07T17:34:46Z Snapshot: ba1efece969b2bc0eb736023c7dae5f3ba8dc77de6339338dbcd3fbf077d99ad Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember View: https://fundies.io/companies/dart/00606886/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=KRW&dimensions=ifrs-full%3AConsolidatedAndSeparateFinancialStatementsAxis%3Difrs-full%3AConsolidatedMember Input fundies:OperatingCashFlow: -11012139984 KRW (2025-01-01 to 2025-12-31) Dimensions: ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember Source: https://opendart.fss.or.kr/api/fnlttXbrl.xml?rcept_no=20260324000019&reprt_code=11011#380257 Filing: 20260324000019 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

41 filings · 3,040 latest values · 3,040 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 00606886, 183490, dart:00606886

Also known as 엔지켐생명과학

엔지켐생명과학

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation